DelphX Announces Non-Brokered Unit Private Placement

Rhea-AI Summary

DelphX (OTCQB: DPXCF; TSXV: DELX) intends to proceed with a non-brokered private placement of 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000. Each Unit comprises one common share and one warrant. Each warrant entitles the holder to buy one common share at C$0.08 for a two-year period from issuance. Completion is subject to TSX Venture Exchange approval. Securities issued will be subject to a four months plus one day hold period. DelphX intends to use net proceeds for general corporate purposes.

Positive

• Gross proceeds C$60,000 from 1,200,000 units
• Each unit includes a one-for-one warrant exercisable at C$0.08 for two years
• Proceeds allocated to general corporate purposes

Negative

• Potential dilution from 1,200,000 shares plus up to 1,200,000 warrant shares
• Low capital raise (C$60,000) may be immaterial to large financing needs
• Issuance subject to TSXV approval, creating completion risk

Toronto, Ontario--(Newsfile Corp. - November 12, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of 1,200,000 units (the "Units") at a subscription price of C$0.05 per Unit, for gross proceeds of C$60,000. Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/274249

FAQ

What is the size and price of the DelphX (DPXCF) non-brokered unit private placement announced November 12, 2025?

DelphX is offering 1,200,000 units at C$0.05 per unit for gross proceeds of C$60,000.

What does each DelphX (DPXCF) Unit include and what are the warrant terms?

Each Unit includes one common share and one warrant; each warrant is exercisable for one share at C$0.08 for two years from issuance.

When will the DelphX (DPXCF) offering close and what approvals are needed?

Completion is subject to TSX Venture Exchange approval; the announcement does not specify a closing date.

How will DelphX (DPXCF) use the proceeds from the private placement?

DelphX intends to use net proceeds for general corporate purposes.

Are there trading restrictions on securities issued in the DelphX (DPXCF) private placement?

Yes; securities issued will be subject to a four months plus one day hold period from issuance.

What is the potential shareholder impact of the DelphX (DPXCF) unit offering?

The offering creates potential dilution from 1,200,000 new shares plus up to 1,200,000 warrant shares if warrants are exercised.